Physician profile
Adel R Malati
NPI 1740286467
$1,618.26
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2020: $662 · 2021: $556.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $232.24 | 2019-2021 | |
| Pfizer INC. | $145.82 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $138.41 | 2019-2020 | |
| Glaxosmithkline, LLC. | $127.96 | 2020-2021 | |
| Novo Nordisk INC | $112.80 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $98.24 | 2019-2021 | |
| Astellas Pharma US INC | $98.03 | 2019-2021 | |
| Lilly USA, LLC | $90.68 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $82.83 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $74.35 | 2019-2021 | |
| Acadia Pharmaceuticals INC | $73.44 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $63.57 | 2019-2021 | |
| Allergan, INC. | $53.43 | 2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $48.68 | 2020-2021 | |
| Abbvie INC. | $44.03 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $40.05 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $22.19 | 2020 | |
| Amarin Pharma, INC. | $17.47 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.80 | 2019 | |
| Biogen, INC. | $13.97 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.42 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.85 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adel Malati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.